PATENT CLAIM ANALYSIS

Application Number: 15745789
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "655000"]

Abstract:
Methods for increasing susceptibility of cancer cells to immunotherapeutic agents and methods for assessing the effectiveness of a cancer treatment.

Claim (Index 17):
An in vitro method for assessing the effectiveness of a therapy administered to a subject with a CaSR expressing cancer, comprising the following steps:\n a) quantifying the expression level of a CTA gene in a biological sample from said subject before and after the therapy, and b) comparing the expression level of the CTA gene in the biological samples, wherein the therapy comprises administration of a CaSR activator agent and wherein an increase of the expression level of the CTA gene after the therapy with respect to the expression level of said CTA gene before the therapy, is indicative that the therapy is effective.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['10485351', '15616672', '14926372', '14346693', '15253307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.724871988419491
- 35 USC 102 Novelty (BERT): 0.5078759118017524
- Combined Prediction Score: 0.7031723807577172
- Mean Citation Score: 195.007452
- Max Citation Score: 224.70102000000003
- Similarity Product: 134.19331890242458

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test